The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targets
Open accessAbstract
Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non‐coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer and many other cancer types. Some lncRNAs have also been used as adjunct to improve the specificity and sensitivity of existing biomarkers. The molecular tools such as RNA‐seq, RNA‐FISH, ic‐SHAPE and quantitative real‐time PCR have been used for examining the lncRNAs' potential. Some lncRNAs such as PCA3 is now routinely used in the clinic for the diagnosis of prostate cancer. Single nucleotide polymorphisms (SNPs) in lncRNAs can also be used as a predictor of cancer risk. Although ongoing studies continue to unravel the underlying mechanism, some lncRNAs have been used as therapeutic targets for the selective killing of cancer cells in patients. Thus lncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target. Companies such as the Curna Inc., MiNA Therapeutics Ltd. and RaNA Therapeutics Inc. have been taking steps to develop lncRNA based strategies against cancer. In this review, we discuss the potential of lncRNAs as biomarkers and therapeutic targets in cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Molecular Mechanisms of Long Noncoding RNAs
Wang, K. C., & Chang, H. Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.018 · Cited by 4,396
Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S., & Manolio, T. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903103106 · Cited by 4,013
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290
Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., Thomas, K., Presser, A., Bernstein, B. E., van Oudenaarden, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904715106 · Cited by 2,872
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
The emerging role of lncRNAs in cancer
Huarte, M. (2015) · Nature Medicine · doi:10.1038/nm.3981 · Cited by 2,702
Modular regulatory principles of large non-coding RNAs
Guttman, M., & Rinn, J. L. (2012) · Nature · doi:10.1038/nature10887 · Cited by 2,265
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
Wang, K. C., Yang, Y. W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y., Lajoie, B. R., Protacio, A., Flynn, R. A., Gupta, R. A., et al. (2011) · Nature · doi:10.1038/nature09819 · Cited by 1,976
Heidenreich, A., Bastian, P. J., Bellmunt, J., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.09.046 · Cited by 1,936
lincRNAs act in the circuitry controlling pluripotency and differentiation
Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., Young, G., Lucas, A. B., Ach, R., Bruhn, L., et al. (2011) · Nature · doi:10.1038/nature10398 · Cited by 1,858
The Emergence of lncRNAs in Cancer Biology
Prensner, J. R., & Chinnaiyan, A. M. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0209 · Cited by 1,770
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs
The FANTOM Consortium and the RIKEN Genome Exploration Research Group Phase I & II Team* (2002) · Nature · doi:10.1038/nature01266 · Cited by 1,642
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
Hung, T., Wang, Y., Lin, M. F., Koegel, A. K., Kotake, Y., Grant, G. D., Horlings, H. M., Shah, N., Umbricht, C., Wang, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.848 · Cited by 1,163
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
Bussemakers, M. J. G., van Bokhoven, A., Verhaegh, G. W. C. T., Smit, F. P., Karthaus, H. F. M., Schalken, J. A., Debruyne, F. M. J., Ru, N., & Isaacs, W. B. (1999) · PubMed · Cited by 1,051
LincRNA-p21 Suppresses Target mRNA Translation
Yoon, J.-H., Abdelmohsen, K., Srikantan, S., Yang, X., Martindale, J. L., De, S., Huarte, M., Zhan, M., Becker, K. G., & Gorospe, M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.027 · Cited by 962
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Yin, H., Xue, W., Chen, S., Bogorad, R. L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P. A., Jacks, T., & Anderson, D. G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2884 · Cited by 951
Tripathi, V., Shen, Z., Chakraborty, A., Giri, S., Freier, S. M., Wu, X., Zhang, Y., Gorospe, M., Prasanth, S. G., Lal, A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003368 · Cited by 754
Hangauer, M. J., Vaughn, I. W., & McManus, M. T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003569 · Cited by 738
Long noncoding RNAs and the genetics of cancer
Cheetham, S. W., Gruhl, F., Mattick, J. S., & Dinger, M. E. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.233 · Cited by 724
Yang, Z., Zhou, L., Wu, L.-M., Lai, M.-C., Xie, H.-Y., Zhang, F., & Zheng, S.-S. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1581-y · Cited by 708
DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer
Hessels, D., Klein Gunnewiek, J. M. T., van Oort, I., Karthaus, H. F. M., van Leenders, G. J. L., van Balken, B., Kiemeney, L. A., Witjes, J. A., & Schalken, J. A. (2003) · European Urology · doi:10.1016/s0302-2838(03)00201-x · Cited by 704
Long Intergenic Noncoding RNAs: New Links in Cancer Progression
Tsai, M.-C., Spitale, R. C., & Chang, H. Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2483 · Cited by 641
Yang, F., Zhang, L., Huo, X.-S., Yuan, J.-H., Xu, D., Yuan, S.-X., Zhu, N., Zhou, W.-P., Yang, G.-S., Wang, Y.-Z., et al. (2011) · Hepatology · doi:10.1002/hep.24563 · Cited by 632
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
Büller, H. R., Bethune, C., Bhanot, S., Gailani, D., Monia, B. P., Raskob, G. E., Segers, A., Verhamme, P., & Weitz, J. I. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405760 · Cited by 630
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
de Kok, J. B., Verhaegh, G. W. C. T., Roelofs, R., Hessels, D., Kiemeney, L. A. L. M., Aalders, T. W., Swinkels, D. W., & Schalken, J. A. (2002) · PubMed · Cited by 607
Lai, M.-C., Yang, Z., Zhou, L., Zhu, Q.-Q., Xie, H.-Y., Zhang, F., Wu, L.-M., Chen, L.-M., & Zheng, S.-S. (2012) · Medical Oncology · doi:10.1007/s12032-011-0004-z · Cited by 596
Translational Research in Traumatic Brain Injury
(2016) · CRC Press eBooks · doi:10.1201/b18959 · Cited by 540
Targeting long non-coding RNA to therapeutically upregulate gene expression
Wahlestedt, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4018 · Cited by 532
APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer
Groskopf, J., Aubin, S. M., Deras, I. L., Blase, A., Bodrug, S., Clark, C., Brentano, S., Mathis, J., Pham, J., Meyer, T., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.063289 · Cited by 529
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
Meng, L., Ward, A. J., Chun, S., Bennett, C. F., Beaudet, A. L., & Rigo, F. (2015) · Nature · doi:10.1038/nature13975 · Cited by 518
Wang, X.-S., Zhang, Z., Wang, H.-C., Cai, J.-L., Xu, Q.-W., Li, M.-Q., Chen, Y.-C., Qian, X.-P., Lu, T.-J., Yu, L.-Z., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0134 · Cited by 480
PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
Deras, I. L., Aubin, S. M. J., Blase, A., Day, J. R., Koo, S., Partin, A. W., Ellis, W. J., Marks, L. S., Fradet, Y., Rittenhouse, H., et al. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.11.038 · Cited by 453
PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat Biopsy
Marks, L. S., Fradet, Y., Deras, I. L., et al. (2007) · Urology · doi:10.1016/j.urology.2006.12.014 · Cited by 447
Long Noncoding RNAs with snoRNA Ends
Yin, Q.-F., Yang, L., Zhang, Y., Xiang, J.-F., Wu, Y.-W., Carmichael, G. G., & Chen, L.-L. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.033 · Cited by 444
Wang, F., Yuan, J.-H., Wang, S.-B., Yang, F., Yuan, S.-X., Ye, C., Yang, N., Zhou, W.-P., Li, W.-L., Li, W., et al. (2014) · Hepatology · doi:10.1002/hep.27239 · Cited by 440
Large Intervening Non-Coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression
Geng, Y., Xie, S., Li, Q., Ma, J., & Wang, G. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900608 · Cited by 407
NONCODEv4: exploring the world of long non-coding RNA genes
Xie, C., Yuan, J., Li, H., Li, M., Zhao, G., Bu, D., Zhu, W., Wu, W., Chen, R., & Zhao, Y. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1222 · Cited by 400
Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish
Xiao, A., Wang, Z., Hu, Y., Wu, Y., Luo, Z., Yang, Z., Zu, Y., Li, W., Huang, P., Tong, X., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt464 · Cited by 392
Yuan, S.-X., Yang, F., Yang, Y., Tao, Q.-F., Zhang, J., Huang, G., Yang, Y., Wang, R.-Y., Yang, S., Huo, X.-S., et al. (2012) · Hepatology · doi:10.1002/hep.25895 · Cited by 374
Cancer drug discovery by repurposing: teaching new tricks to old dogs
Gupta, S. C., Sung, B., Prasad, S., Webb, L. J., & Aggarwal, B. B. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.06.005 · Cited by 340
Yao, Y., Ma, J., Xue, Y., Wang, P., Li, Z., Liu, J., Chen, L., Xi, Z., Teng, H., Wang, Z., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.051 · Cited by 338
The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases
Wang, B., Zhang, S., Yue, K., & Wang, X.-D. (2013) · Chinese Journal of Cancer · doi:10.5732/cjc.012.10219 · Cited by 329
Ma, M.-Z., Chu, B.-F., Zhang, Y., Weng, M.-Z., Qin, Y.-Y., Gong, W., & Quan, Z.-W. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.541 · Cited by 328
Ren, S., Wang, F., Shen, J., Sun, Y., Xu, W., Lu, J., Wei, M., Xu, C., Wu, C., Zhang, Z., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.026 · Cited by 312
Non‐coding RNAs: Meet thy masters
Costa, F. F. (2010) · BioEssays · doi:10.1002/bies.200900112 · Cited by 312
Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility
Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01737.x · Cited by 286
DD3 RNA Analysis in Urine ? A New Perspective for Detecting Prostate Cancer
TINZL, M., MARBERGER, M., HORVATH, S., & CHYPRE, C. (2004) · European Urology · doi:10.1016/j.eururo.2004.06.004 · Cited by 283
Zhuang, W., Ge, X., Yang, S., Huang, M., Zhuang, W., Chen, P., Zhang, X., Fu, J., Qu, J., & Li, B. (2015) · Stem Cells · doi:10.1002/stem.1989 · Cited by 274
Berrondo, C., Flax, J., Kucherov, V., Siebert, A., Osinski, T., Rosenberg, A., Fucile, C., Richheimer, S., & Beckham, C. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147236 · Cited by 266
Prensner, J. R., Zhao, S., Erho, N., Schipper, M., Iyer, M. K., Dhanasekaran, S. M., Magi-Galluzzi, C., Mehra, R., Sahu, A., Siddiqui, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71113-1 · Cited by 264
Long Noncoding RNAs in Cancer: From Function to Translation
Sahu, A., Singhal, U., & Chinnaiyan, A. M. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.08.010 · Cited by 260
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
Ho, T.-T., Zhou, N., Huang, J., Koirala, P., Xu, M., Fung, R., Wu, F., & Mo, Y.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1198 · Cited by 244
Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
Wong, A. S. L., Choi, G. C. G., Cui, C. H., Pregernig, G., Milani, P., Adam, M., Perli, S. D., Kazer, S. W., Gaillard, A., Hermann, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517883113 · Cited by 242
Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer
Guo, H., Ahmed, M., Zhang, F., Yao, C. Q., Li, S., Liang, Y., Hua, J., Soares, F., Sun, Y., Langstein, J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3637 · Cited by 226
Liu, Y.-R., Jiang, Y.-Z., Xu, X.-E., Yu, K.-D., Jin, X., Hu, X., Zuo, W.-J., Hao, S., Wu, J., Liu, G.-Y., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0690-8 · Cited by 226
Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis
TANG, H., WU, Z., ZHANG, J., & SU, B. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1254 · Cited by 219
Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk
Gail, M. H. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn180 · Cited by 218
C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion
He, X., Tan, X., Wang, X., Jin, H., Liu, L., Ma, L., Yu, H., & Fan, Z. (2014) · Tumor Biology · doi:10.1007/s13277-014-2526-4 · Cited by 217
Ma, M.-Z., Li, C.-X., Zhang, Y., Weng, M.-Z., Zhang, M.-D., Qin, Y.-Y., Gong, W., & Quan, Z.-W. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-156 · Cited by 216
Oral cavity cancer in developed and in developing countries: Population‐based incidence
de Camargo Cancela, M., Voti, L., Guerra‐Yi, M., Chapuis, F., Mazuir, M., & Curado, M. P. (2010) · Head & Neck · doi:10.1002/hed.21193 · Cited by 216
WU, Z.-H., WANG, X.-L., TANG, H.-M., JIANG, T., CHEN, J., LU, S., QIU, G.-Q., PENG, Z.-H., & YAN, D.-W. (2014) · Oncology Reports · doi:10.3892/or.2014.3186 · Cited by 214
Long non-coding RNA HOTAIR is associated with human cervical cancer progression
KIM, H. J., LEE, D. W., YIM, G. W., NAM, E. J., KIM, S., KIM, S. W., & KIM, Y. T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2014.2758 · Cited by 212
Regulation of Apoptosis by a Prostate-Specific and Prostate Cancer-Associated Noncoding Gene, PCGEM1
Fu, X., Ravindranath, L., Tran, N., Petrovics, G., & Srivastava, S. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.135 · Cited by 209
Dong, L. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1413 · Cited by 200
Jiang, Y.-Z., Liu, Y.-R., Xu, X.-E., Jin, X., Hu, X., Yu, K.-D., & Shao, Z.-M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3284 · Cited by 192
Identification of Novel Long Noncoding RNAs Underlying Vertebrate Cardiovascular Development
Kurian, L., Aguirre, A., Sancho-Martinez, I., Benner, C., Hishida, T., Nguyen, T. B., Reddy, P., Nivet, E., Krause, M. N., Nelles, D. A., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013303 · Cited by 189
Long Non-Coding RNAs: Challenges for Diagnosis and Therapies
Sánchez, Y., & Huarte, M. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0414 · Cited by 187
Wang, F., Ren, S., Chen, R., Lu, J., Shi, X., Zhu, Y., Zhang, W., Jing, T., Zhang, C., Shen, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2691 · Cited by 180
Casero, D., Sandoval, S., Seet, C. S., Scholes, J., Zhu, Y., Ha, V. L., Luong, A., Parekh, C., & Crooks, G. M. (2015) · Nature Immunology · doi:10.1038/ni.3299 · Cited by 179
Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9
Han, J., Zhang, J., Chen, L., Shen, B., Zhou, J., Hu, B., Du, Y., Tate, P. H., Huang, X., & Zhang, W. (2014) · RNA Biology · doi:10.4161/rna.29624 · Cited by 168
Beaulieu, Y. B., Kleinman, C. L., Landry-Voyer, A.-M., Majewski, J., & Bachand, F. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003078 · Cited by 166
Non-coding RNAs: Lost in translation?
Costa, F. F. (2006) · Gene · doi:10.1016/j.gene.2006.09.028 · Cited by 158
Sidi, A. A., Ohana, P., Benjamin, S., Shalev, M., Ransom, J. H., Lamm, D. L., Hochberg, A., & Leibovitch, I. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.08.006 · Cited by 157
Cho, S., Chang, Y. C., Chang, C., Lin, S.-F., Liu, Y., Hsiao, H., Chang, J., & Liu, T. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-809 · Cited by 157
Long non-coding RNAs as prognostic markers in human breast cancer
Liu, H., Li, J., Koirala, P., Ding, X., Chen, B., Wang, Y., Wang, Z., Wang, C., Zhang, X., & Mo, Y.-Y. (2016) · Oncotarget · doi:10.18632/oncotarget.7828 · Cited by 155
Expression and Function of a Large Non‐coding RNA Gene XIST in Human Cancer
Weakley, S. M., Wang, H., Yao, Q. C., & Chen, C. (2011) · World Journal of Surgery · doi:10.1007/s00268-010-0951-0 · Cited by 148
Xu, S., Sui, S., Zhang, J., Bai, N.-X., Shi, Q., Zhang, G., Gao, S., You, Z., Zhan, C., Liu, F., et al. (2015) · PubMed Central · Cited by 146
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
Ariel, I. (2000) · Molecular Pathology · doi:10.1136/mp.53.6.320 · Cited by 146
Hanna, N. N., Ohana, P., Konikoff, F. M., Leichtmann, G. A., Hubert, A., Appelbaum, L., Kopelman, Y., Czerniak, A., & Hochberg, A. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.10 · Cited by 143
Polymorphisms in the H19 Gene and the Risk of Bladder Cancer
Verhaegh, G. W. C. T., Verkleij, L., Vermeulen, S. H. H. M., den Heijer, M., Witjes, J. A., & Kiemeney, L. A. L. M. (2008) · European Urology · doi:10.1016/j.eururo.2008.01.060 · Cited by 141
Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells
Burzio, V. A., Villota, C., Villegas, J., Landerer, E., Boccardo, E., Villa, L. L., Martínez, R., López, C., Fancy Gaete, V., Toro, V., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903086106 · Cited by 141
Ma, X., Wang, J., Wang, J., Charles, X., Wang, X., & Liu, F. (2015) · BMC Genomics · doi:10.1186/s12864-015-1881-x · Cited by 139
Ono, H., Motoi, N., Nagano, H., Miyauchi, E., Ushijima, M., Matsuura, M., Okumura, S., Nishio, M., Hirose, T., Inase, N., et al. (2014) · Cancer Medicine · doi:10.1002/cam4.220 · Cited by 139
Salvador, M. A., Wicinski, J., Cabaud, O., Toiron, Y., Finetti, P., Josselin, E., Lelièvre, H., Kraus‐Berthier, L., Depil, S., Bertucci, F., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0877 · Cited by 133
The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer
Malik, R., Patel, L. R., Prensner, J. R., Shi, Y., Iyer, M. K., Subramaniyan, S., Carley, A., Niknafs, Y. S., Sahu, A., Han, S., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0257 · Cited by 133
Tantai, J., Hu, D., Yang, Y. P., & Geng, J. (2015) · PubMed · Cited by 131
Impact of Comorbidity, Symptoms, and Patients' Characteristics on the Prognosis of Oral Carcinomas
Ribeiro, K. B., Kowalski, L. P., & Latorre, M. D. R. D. D. O. (2000) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.126.9.1079 · Cited by 127
Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk
Jin, G., Sun, J., Isaacs, S. D., Wiley, K. E., Kim, S., Chu, L. W., Zhang, Z., Zhao, H., Zheng, S. L., Isaacs, W. B., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr187 · Cited by 126
DrugTargetSeqR: a genomics- and CRISPR-Cas9–based method to analyze drug targets
Kasap, C., Elemento, O., & Kapoor, T. M. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1551 · Cited by 124
Ye, Y., Chen, J., Zhou, Y., Fu, Z., Zhou, Q., Wang, Y., Gao, W., Zheng, S., Zhao, X., Chen, T., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0490-4 · Cited by 117
Gofrit, O. N., Benjamin, S., Halachmi, S., Leibovitch, I., Dotan, Z., Lamm, D. L., Ehrlich, N., Yutkin, V., Ben‐Am, M., & Hochberg, A. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.12.011 · Cited by 114
Yang, L., Hs, B., Deng, Y., & Fan, L. (2015) · PubMed · Cited by 112
Shi, W., Wu, Q., Li, S., Yang, T., Liu, Z.-H., Tong, Y., Tuo, L., Wang, S., & Cao, X. (2015) · Tumor Biology · doi:10.1007/s13277-014-2863-3 · Cited by 108
Lessard, L., Liu, M., Marzese, D. M., Wang, H., Chong, K. K., Kawas, N. P., Donovan, N. C., Kiyohara, E., Hsu, S. C., Nelson, N. E., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.200 · Cited by 106
Promoter Hypermethylation of the MEG3 (DLK1/MEG3) Imprinted Gene in Multiple Myeloma
Benetatos, L., Dasoula, A., Hatzimichael, E. C., Georgiou, I. A., Syrrou, M., & Bourantas, K. L. (2008) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2008.n.021 · Cited by 106
Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells
Landerer, E., Villegas, J., Burzio, V. A., de Oliveira, L. R., Villota, C., López, C., Restovic, F., Martínez, R., Castillo, O., & Burzio, L. O. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0018-8 · Cited by 105
Expression of a novel non-coding mitochondrial RNA in human proliferating cells
Villegas, J., Burzio, V. A., Villota, C., Landerer, E., Martínez, R., Santander, M., Martinez, R., Pinto, R. O., Vera, M. I., Boccardo, E., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm863 · Cited by 103
SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma
Zhang, T., Cao, C., Wu, D., & Liu, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-4052-4 · Cited by 98
Karlsson, O., Rodosthenous, R. S., Jara, C., Brennan, K. J. M., Wright, R. O., Baccarelli, A., & Wright, R. J. (2016) · Epigenetics · doi:10.1080/15592294.2016.1216285 · Cited by 91
Li, L., Sun, R., Liang, Y., Pan, X.-M., Li, Z., Bai, P., Zeng, X., Zhang, D., Zhang, L., & Gao, L. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-104 · Cited by 89
Long Noncoding RNAs as Putative Biomarkers for Prostate Cancer Detection
Lee, B., Mazar, J., Aftab, M. N., Qi, F., Shelley, J. P., Li, J., Govindarajan, S. S., Valerio, F., Rivera, I., Thurn, T., et al. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.06.009 · Cited by 89
Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
Shen, Y., Katsaros, D., Loo, L. W. M., Hernandez, B. Y., Chong, C. D. K., Canuto, E. M., Biglia, N., Lu, L., Risch, H. A., Chu, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3287 · Cited by 88
Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?
Srinivasan, S., Clements, J. A., & Batra, J. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1075469 · Cited by 88
Li, J., Wang, Y., Yu, J., Dong, R., & Qiu, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2765-4 · Cited by 83
Functions and Mechanisms of Long Noncoding RNAs in Ovarian Cancer
Ren, C., Li, X., Wang, T., Wang, G., Zhao, C., Liang, T., Zhu, Y., Li, M., Yang, C., Zhao, Y., et al. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000413 · Cited by 83
Aberrant NEAT 1 expression is associated with clinical outcome in high grade glioma patients
He, C., Jiang, B., Jian-rong, M., & Li, Q. (2015) · Apmis · doi:10.1111/apm.12480 · Cited by 83
Fatemi, R. P., Velmeshev, D., & Faghihi, M. A. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.45 · Cited by 76
Association between lncrna PCGEM1 polymorphisms and prostate cancer risk
Xue, Y., Wang, M., Kang, M., Wang, Q., Wu, B., Chu, H., Zhong, D., Qin, C., Yin, C., Zhang, Z., et al. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2013.6 · Cited by 75
Shen, Z., Li, Q., Deng, H., Lu, D., Song, H., & Guo, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108237 · Cited by 74
Zhang, Z., Weaver, D. L., Olsen, D., deKay, J., Peng, Z., Ashikaga, T., & Evans, M. F. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203275 · Cited by 73
Ma, M., Kong, X., Weng, M., Zhang, M., Qin, Y., Gong, W., Zhang, W., & Quan, Z. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22215 · Cited by 72
Genetic variants in lncRNAH19are associated with the risk of bladder cancer in a Chinese population
Hua, Q., Lv, X. L., Gu, X. Q., Chen, Y., Chu, H., Du, M., Gong, W., Wang, M., & Zhang, Z. (2016) · Mutagenesis · doi:10.1093/mutage/gew018 · Cited by 72
Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder
Srivastava, A. K., Singh, P. K., Rath, S. K., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2474-z · Cited by 67
HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis.
Hao, S., & Shao, Z. (2015) · Europe PMC (PubMed Central) · Cited by 66
Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer
Martínez‐Fernández, M., Feber, A., Dueñas, M., Segovia, C., Rubio, C., Fernandez, M., Villacampa, F., Duarte, J. M., López-Calderón, F., Gómez-Rodriguez, M. J., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0141-x · Cited by 63
Aberrant Expression of CCAT1 Regulated by c-Myc Predicts the Prognosis of Hepatocellular Carcinoma
Zhu, H., Zhou, X., Chang, H., Li, H., Liu, F., Ma, C., & Lu, J. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.13.5181 · Cited by 60
Villota, C., Campos, A. V., Vidaurre, S., Oliveira-Cruz, L., Boccardo, E., Burzio, V. A., Varas‐Godoy, M., Villegas, J., Villa, L. L., Valenzuela, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326694 · Cited by 60
Ma, S., LI, A.-J., Hu, Z., Shang, F., & Wu, M. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4435 · Cited by 60
Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence
Glover, A. R., Zhao, J., Ip, J. C. Y., Lee, J. C., Robinson, B. G., Gill, A. J., Soon, P., & Sidhu, S. B. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0457 · Cited by 59
Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer
Liu, B., Shen, E., Liao, M., Hu, Y., Wu, K., Yang, P., Zhou, L., & Chen, W. (2016) · Tumor Biology · doi:10.1007/s13277-016-4863-y · Cited by 57
Noveck, R. J., Stroes, E. S. G., Flaim, J., Baker, B. F., Hughes, S. G., Graham, M. J., Crooke, R. M., & Ridker, P. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001084 · Cited by 49
Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma
Li, Y., Wang, T., Li, Y., CHEN, D., Yu, Z., Lu, J., Ni, L., Yang, S., Mao, X., Gui, Y., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4894 · Cited by 43
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
Kok, J. B. D., Verhaegh, G. W. C. T., Roelofs, R. W. H. M., et al. (2002) · Radboud Repository (Radboud University) · Cited by 40
Prognostic Value of Long Non-Coding RNA HOTAIR in Various Cancers
Deng, Q., Sun, H., He, B., Pan, Y., Gao, T., Chen, J., Ying, H., Liu, X., Wang, F., Xu, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110059 · Cited by 37
Fan, Q., Yu, R., Huang, W.-X., Cui, X., Luo, B., & Zhang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090008 · Cited by 30
Non-coding RNAs and new opportunities for the private sector
Costa, F. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.01.008 · Cited by 30
Jiang, C., Gao, Y., Wang, X., Ruan, Y., Bei, X., Wang, X., Jing, Y., Zhao, W., Jiang, Q., Li, J., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.056 · Cited by 26
Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population
Cao, D.-L., Gu, C.-Y., Zhu, Y., Dai, B., Zhang, H.-L., Shi, G.-H., Shen, Y., Zhu, Y.-P., Ma, C.-G., Xiao, W.-J., et al. (2014) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2014.34 · Cited by 19
Non-coding RNAs: could they be the answer?
Costa, F. F. (2010) · Briefings in Functional Genomics · doi:10.1093/bfgp/elq029 · Cited by 9
Cited by
Biomarkers of gastric cancer: Current topics and future perspective
Matsuoka, T., & Yashiro, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i26.2818 · Cited by 476
Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer
Goyal, B., Yadav, S. R. M., Awasthee, N., Gupta, S., Kunnumakkara, A. B., & Gupta, S. C. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188502 · Cited by 358
Gao, N., Li, Y., Li, J., Gao, Z., Yang, Z., Li, Y., Liu, H., & Fan, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.598817 · Cited by 304
Zhang, G., Li, S., Lu, J., Ge, Y., Wang, Q., Ma, G., Zhao, Q., Wu, D., Gong, W., Du, M., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0829-6 · Cited by 272
Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy
Qian, Y., Shi, L., & Luo, Z. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.612393 · Cited by 261
Metadata
- Authors
- Chandra Gupta, S., & Nandan Tripathi, Y.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2016-12-30
- Volume
- 140
- Issue
- 9
- Pages
- 1955-1967
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2783395490
- Cited by
- 527
- References
- 134
- FWCI
- 17.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.